Lymphedema involves the accumulation of lymph fluid in fatty tissues just beneath the skin. The condition is caused due to impaired flow in the lymphatic system of a person and is observed either in the legs or arms or in both of them. It can also affect the abdomen, neck, genitals, and face of a person, depending on the portion of the body which has undergone treatment. Primary lymphedema is generally present at birth, while secondary lymphedema is caused due to dysfunction or damage to the lymphatic system. Cancer-related treatment is a prominent cause of secondary lymphedema. Surgery, radiation therapy, or cancer itself can hinder the flow of lymph fluid, leading to lymphedema. Symptoms of lymphedema include feeling of tightness or heaviness; swelling in the legs, arms, or other parts of the body; ache or discomfort; and fibrosis, which means thickening or hardening of the skin.
Rise in the number of lymphedema cases globally is a prominent factor driving the growth of the global lymphedema treatment market. According to some estimates, 140-250 million people across the globe are affected by lymphedema. In the U.S., around 1-2 million people suffer from primary lymphedema, while 2-3 million are affected with secondary lymphedema. Rise in incidence of cancer, especially breast cancer, is another factor boosting the number of lymphedema cases globally. Patients undergoing radiation therapy or surgery for breast cancer treatment are at a high risk of developing lymphedema. Breast cancer is the most commonly observed cancer among women and is the second-most common type of cancer. According to the World Cancer Research Fund, an estimated 2 million cases of breast cancer were reported in 2018 across the world.
Launch of new medical devices by companies is another factor contributing to the growth of the global lymphedema treatment market. In May 2017, Tactile Systems Technology, Inc., a prominent manufacturer of at-home therapy devices, announced the launch of Flexitouch system in the U.S. market. Flexitouch system is a pneumatic compression device for use in the treatment of lymphedma of neck and head. The device, which was granted approval by the U.S. Food and Drug Administration (FDA) in September 2016, is the only pneumatic compression system that can deliver non-invasive therapy to patients and can help in stimulating their lymphatic system.
Ongoing research for the development of novel therapies for the treatment of lymphedema is another driver of the global lymphedema treatment market. According to a new study conducted at the Stanford University School of Medicine, a new molecular mechanism primarily responsible for causing lymphedema, along with a drug (bestatin) which has the potential for hindering the process, was uncovered in May 2017. Bestatin is currently undergoing clinical trials for the treatment of secondary lymphedema. Positive outcome from the trials is expected to be a step forward toward developing new treatment option for the management of lymphedema.
The global lymphedema treatment market can be segmented based on treatment type, end-user, and region. In terms of treatment type, the market can be classified into surgery, compression therapy, and others. Based on end-user, the lymphedema treatment market can be divided into hospitals, clinics, and others.
In terms of geography, the global lymphedema treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global lymphedema treatment market due to launch of new products for the management of the condition. North America is followed by Europe and Asia Pacific in terms of dominance over the global lymphedema treatment market. In Asia Pacific, increasing incidence of breast cancer is likely to fuel the growth of the lymphedema treatment market during the forecast period.
Prominent players operating in the global lymphedema treatment market include Bio Compression Systems, Inc., BSN medical, Lohmann & Rauscher, Mego Afek ltd, SIGVARIS, and Tactile Systems Technology Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.